A Epidermolysis Bullosa Market, by Product Type (Antibiotics

Epidermolysis Bullosa Market, by Product Type (Antibiotics, Analgesics, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Epidermolysis bullosa is a genetic disorder characterized clinically by blister formation from mechanical trauma. There are four main types with additional sub-types identified. There is a spectrum of severity, and within each type, one may be either midely or severely affected. Epidermolysis bullosa range from being a minor inconvenience requiring modification of some activities, to being completely disabling and, in some cases, fatal.

Friction causes blister formation, blisters can form anywhere on the surface of the skin, within the oral cavity and in more severe forms many also involve the external surface of the eyes, as well as the respiratory, gastrointestinal and genitourinary tracts. In some form of the dieases,disfiguring scars and disabling musculoskeletal deformities occur.

Market Dynamics

The increasing prevalence of epidermolysis bullosa globally, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the global epidermolysis bullosa market over the forecast period.

For instance, in March 2020, Abeona Therapeutics Inc., a gene and cell development company announced that the first patient treated in a pivotal phase III clinical trial evaluating EB - 101 gene therapy for recessive dystrophic epidermolysis bullosa.

Key features of the study:

  • This report provides an in-depth analysis of the global epidermolysis bullosa market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global epidermolysis bullosa market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Amryt Pharma, Abeona Therapeutics, Castle Creek Pharmaceuticals, RegeneRx, Krystal Biotech, RHEACELL GmbH, Holostem Terapie Avanzate, StemRim/Shionogi, and Phoenix Tissue Repair
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global epidermolysis bullosa market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global epidermolysis bullosa market
Detailed Segmentation:
  • Global Epidermolysis Bullosa Market, By Product Type:
  • Antibiotic
  • Analgesics
  • Others
  • Global Epidermolysis Bullosa Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Epidermolysis Bullosa Market, By Region:
  • North America
  • By Country
  • U.S.
  • Canada
  • Latin America
  • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Country/Region
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Amryt Pharma.*
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Abeona Therapeutics
  • Castle Creek Pharmaceuticals
  • RegeneRx
  • Krystal Biotech
  • RHEACELL GmbH
  • Holostem Terapie Avanzate
  • StemRim/Shionogi
  • Phoenix Tissue Repair
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Mergers & Acquisitions
4. Global Epidermolysis Bullosa Market – Impact of Coronavirus (Covid-19) Pandemic
Economic Impact
Impact on Clinical Trials
Government Initiatives
5. Global Epidermolysis Bullosa Market, By Product Type, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Antibiotic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Analgesic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
6. Global Epidermolysis Bullosa Market, By Distribution Channel, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
7. Global Epidermolysis Bullosa Market, By Region, 2017 – 2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2021 and 2028 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2030
North America
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 – 2030, (US$ Mn)
Market Size and Forecast, By Country/Region, 2017 – 2030, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Amryt Pharma
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Abeona Therapeutics
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Castle Creek Pharmaceuticals
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
RegeneRx
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Krystal Biotech
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
RHEACELL GmbH
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Holostem Terapie Avanzate
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
StemRim/Shionogi
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Phoenix Tissue Repair
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 53 market data tables and 38 figures on "Epidermolysis Bullosa Market” - Global forecast t2030.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings